Skip to main content
SpringerLink
Log in

Economic burden of PPH substantial

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was sponsored by Novo Nordisk.

Reference

  • Brod M, et al. The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries. Diabetes Therapy 7: 75-90, No. 1, 22 Feb 2016. Available from: URL: http://doi.org/10.1007/s13300-016-0154-2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Economic burden of PPH substantial. PharmacoEcon Outcomes News 752, 10 (2016). https://doi.org/10.1007/s40274-016-3004-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3004-6

Search

Navigation